LI Wen, et al. Sci China Chem December (2010) Vol.53 No.12
2513
a
6-Amino-2-(3,4,5-tris(2-(2-(2-methoxyethoxy)ethoxy)etho-
xy)benzamido)hexyl alcohol hydrochloride (3c)
CH), 4.36 (br, 1H, CH), 5.58 (s, 1H, CH2 ), 6.10 (s, 1H,
b
CH2 ), 6.48 (br, 1H, NH), 6.55 (br, 1H, NH), 7.05 (s, 2H,
CH), 7.23 (br, 1H, NH). 13C NMR (CD2Cl2): δ 18.22, 23.09,
28.20, 28.30, 29.03, 31.11, 32.79, 39.20, 49.22, 50.25,
53.16, 55.39, 58.72, 59.66, 66.24, 69.08, 69.78, 70.49,
70.51, 70.60, 70.64, 70.68, 70.83, 72.02, 72.04, 72.53,
78.91, 80.63, 106.76, 125.84, 130.03, 136.34, 141.25,
152.61, 155.34, 155.91, 166.68, 167.55, 172.52. HR-MS
(MALDI): m/z calcd for C53H90N4O20Na [M + Na]+ 1125.61;
found 1125.609. Elemental analysis (%) calcd for
C53H90N4O20 (1103.31): C, 57.70; H, 8.22; N, 5.08. Found:
C, 56.79; H, 8.04; N, 4.99.
25% HCl (5.39 g, 36.94 mmol) was added to a solution of
3a (1.52 g, 1.85 mmol) in THF (15 mL) at 0 °C. The mix-
ture was stirred for another 10 h. After evaporation of the
solvent and HCl, the residue was dissolved in water and
washed with DCM. The aqueous phase was collected and 3c
was obtained as a high viscous colorless oil (1.28 g, 91%)
after evaporation of water. 1H NMR (D2O): δ 1.31–1.34 (m,
2H, CH2), 1.44–1.60 (m, 4H, CH2), 2.86 (t, 2H, CH2),
3.21–3.23 (m, 9H, CH3), 3.44–3.64 (m, 26H, CH2), 3.72 (br,
2H, CH2), 3.81 (br, 4H, CH2), 3.98–3.99 (m, 1H, CH), 4.15
(br, 6H, CH2), 7.03 (s, 2H, CH). 13C NMR (D2O): δ 22.44,
26.59, 29.77, 39.42, 51.89, 58.13, 58.15, 63.65, 68.56,
69.33, 69.56, 69.59, 69.66, 69.75, 69.79, 69.96, 70.33,
71.11, 72.21, 106.81, 129.95, 139.92, 151.99, 169.98.
HR-MS (ESI): m/z calcd for C34H62N2O14Na [M+Na]+
745.42; found 745.4054.
(2S,4S)-1-[(2S,4S)-1-(tert-Butoxycarbonyl)-4-(tert-butoxyca-
rbonylamino)pyrrolidine-2-carbonyl]-4-[(2S,4S)-1-(tert-bu-
toxycarbonyl)-4-(tert-butoxy-carbonyl-amino)pyrrolidine-
2-carbonylamino]-proline (6b)
According to general procedure A from LiOH⋅H2O (1.44 g,
34.32 mmol) and compound 6a (3.30 g, 4.29 mmol) in MeOH
(80 mL) and H2O (8 mL). 6b was yielded as a white foam
6-((2S,4S)-1-(tert-Butoxycarbonyl)-4-(tert-butoxycarbonyla-
mino)pyrrolidine-2-carbonylamino)-2-(3,4,5-tris(2-(2-(2-
methoxyethoxy)ethoxy)ethoxy)benzamido)hexyl alcohol (5a)
1
(2.75 g, 85%). H NMR (CD2Cl2): δ 1.24–1.43 (m, 36H,
CH3), 1.85–2.43 (m, 6H, CH2), 3.40–3.73 (m, 5H, CH2 +
b
CH2a), 3.98–4.68 (m, 7H, CH + CH2 ). Only the signal from
According to general procedure C from 3c (0.68 g, 0.90
mmol) and DiPEA (1.16 g, 9.00 mmol) in DCM (3 mL),
and compound 4 (0.67 g, 1.34 mmol) in DCM (25 mL),
purification with column chromatography using DCM/
Boc can be detected in 13C NMR spectrum. HR-MS (ESI): m/z
calcd for C35H58N6O12Na [M+Na]+ 777.41; found 777.4004.
(2S,4S)-1-[(2S,4S)-1-(tert-Butoxycarbonyl)-4-(tert-butoxyca-
rbonylamino)pyrrolidine-2-carbonyl]-4-[(2S,4S)-1-(tert-bu-
toxycarbonyl)-4-(tert-butoxy-carbonyl-amino)pyrrolidine-
2-carbonylamino]-proline pentafluorophenol ester (6c)
:
MeOH (15 1, v/v) afforded 5a as a white solid (0.79 g,
1
85%). H NMR (CD2Cl2): δ 1.39 (br, 20H, CH3+CH2),
1.57–1.65 (m, 4H, CH2), 2.14 (br, 2H, CH2), 3.12 (br, 1H,
CH2 ), 3.25 (br, 2H, CH2 +CH2 ), 3.32 and 3.34 (2s, 9H,
CH3), 3.48–3.69 (m, 27H, CH2+CH2 ), 3.75–3.84 (m, 6H,
CH2), 4.06 (br, 1H, CH), 4.16–4.22 (m, 7H, CH2 + CH),
4.29 (br, 1H, CH), 6.52 (br, 1H, NH), 6.75 (br, 1H, NH),
7.13 (s, 2H, CH), 7.25 (br, 1H, NH). 13C NMR (D2O): δ
23.23, 28.20, 28.29, 29.11, 30.55, 39.12, 50.25, 55.38,
58.72, 59.68, 65.17, 69.21, 69.86, 70.40, 70.51, 70.59,
70.67, 70.73, 72.01, 72.03, 72.51, 78.97, 80.27, 80.71,
107.27, 141.38, 152.57, 155.35, 167.42, 170.46, 172.68.
HR-MS (MALDI): m/z calcd for C49H86N4O19Na [M+Na]+
1057.59; found 1057.576.
a
b
m
n
According to general procedure B from DCC (1.17 g, 5.68
mmol), 6b (1.95 g, 2.58 mmol) and pentafluorophenol (0.95
g, 5.17 mmol) in DCM (40 mL), purification by column
:
chromatography with DCM/MeOH (30 1, v/v) afforded 6c
1
as white foam (1.90 g, 80 %). H NMR (CD2Cl2): δ 1.08–
1.44 (m, 36H, CH3), 1.67–2.20 (m, 5H, CH2+CH2 ), 2.39–
2.47 (m, 1H, CH2 ), 3.29–3.61 (m, 5H, CH2+CH2 ), 4.18–
4.37 (m, 4H, CH+CH2 ), 4.44–4.84 (m, 3H, CH), 6.14–6.33
a
b
m
n
(m, 2H, NH), 7.82 (2br, 1H, NH). 13C NMR (CD2Cl2): δ
25.13, 25.77, 28.07, 28.22, 31.20, 32.44, 33.99, 34.14,
34.27, 35.10, 35.96, 36.37, 49.14, 49.33, 49.40, 50.32,
52.19, 52.34, 54.38, 54.94, 55.17, 56.61, 56.69, 57.57,
57.66, 59.53, 78.82, 79.12, 80.23, 81.01, 137.01, 139.01,
140.24, 142.27, 153.18, 154.41, 155.35, 156.24, 168.35,
172.69, 172.91, 173.03. HR-MS (ESI): m/z calcd for
C41H57F5N6O12Na [M+Na]+ 943.40; found 943.3859.
6-((2S,4S)-1-(tert-Butoxycarbonyl)-4-(tert-butoxycarbonyla-
mino)pyrrolidine-2-carbonylamino)-2-(3,4,5-tris(2-(2-(2-
methoxyethoxy)ethoxy)ethoxy)benzamido)hexyl methacry-
late (5b)
According to general procedure D from 5a (0.88 g, 0.85
mmol), TEA (0.43 g, 4.25 mmol), DMAP (0.10 g), MAC
(0.36 g, 3.40 mmol) and DCM (30 mL), purification with
6-((2S,4S)-1-[(2S,4S)-1-(tert-Butoxycarbonyl)-4-(tert-buto-
:
xycarbonylamino) pyrrolidine-2-carbonyl]-4-[(2S,4S)-1-
(tert-butoxycarbonyl)-4-(tert-butoxy-carbonylamino)pyrro-
lidine-2-carbonylamino]-pyrolidine-2-carbonylamino)-2-
(3,4,5-tris(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)benzami-
do)hexyl alcohol (7a)
column chromatography using DCM/MeOH (20 1, v/v)
1
afforded 5b as a white solid (0.80 g, 85%). H NMR
(CD2Cl2): δ 1.42 (br, 20H, CH3+CH2), 1.57–1.65 (m, 4H,
CH2), 1.92 (s, 3H, CH3), 2.14 (br, 2H, CH2), 3.25 (br, 2H,
CH2), 3.32 and 3.34 (2s, 9H, CH3), 3.49–3.69 (m, 27H, CH2
n
+ CH2 ), 3.75–3.85 (m, 6H, CH2), 4.16–4.27 (m, 10H, CH2+
According to general procedure C, from 3c (0.73 g, 0.96